1712 / 1726
13
EMBRACE II interventions
Increased use of IC/IS technique in BT:
HR CTV >30cm3: utilisation of IC/IS of >70% in patients and CTV
HR
>85Gy in
80% of patients (63% in EMBRACE I))
Reduction of vaginal source loading
Systematic utilisation of IMRT
Utilisation of daily IGRT (set-up according to bony structures)
EBRT target concept related to the primary tumour; concepts for
OAR contouring
EBRT dose prescription (45Gy/25fx) and reporting
Adaptation of EBRT nodal elective CTV according to risk of
nodal and systemic recurrence
Systematic application of simultaneous chemotherapy
Reduction of overall treatment time